J. Michael Pearson

2015 - Valeant Pharmaceuticals International

In 2015, J. Michael Pearson earned a total compensation of $143.1M as Chief Executive Officer at Valeant Pharmaceuticals International, a 1,279% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$2,000,000
Stock Awards$140,304,682
Other$772,760
Total$143,077,442

Pearson received $140.3M in stock awards, accounting for 98.06% of the total pay in 2015.

Pearson also received $2M in non-equity incentive plan and $772.8K in other compensation.

Overall ranking

Ranking

2

out of 13,601
Percentile100th

J. Michael Pearson's 2015 compensation ranked 2nd out of 13,601 executive pay records tracked by us this year.

Pearson earned more than 100.0% of all executives tracked by us in 2015.

Ranking in industry group

Industry groupDrugs
Ranking

2

out of 1,493
Percentile100th

In the industry group of Drugs, Pearson's pay ranked 2nd out of 1,493 executive pay records tracked by us in 2015.

Pearson earned more than 99.9% of executives in this group.

Source: SEC filing on April 29, 2016.

Pearson's colleagues

We found six more compensation records of executives who worked with J. Michael Pearson at Valeant Pharmaceuticals International in 2015.

2015

Robert Rosiello

Valeant Pharmaceuticals International

Chief Financial Officer

2015

Anne Whitaker

Valeant Pharmaceuticals International

Group Chairman

2015

Brian Stolz

Valeant Pharmaceuticals International

Senior Vice President and General Manager

2015

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2015

Ari Kellen

Valeant Pharmaceuticals International

Group Chairman

2015

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

You may also like